Urinary properdin excretion is associated with intrarenal complement activation and poor renal function

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1157-1161

  Siezenga, MacHiel A ^a   Van Der Geest, Reinier N ^a   Mallat, Marko J K ^a   Rabelink, Ton J ^a   Daha, Mohamed R ^a   Berger, Stefan P ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Complement activation; Properdin; Proteinuria; Renal failure

Indexed keywords

PROPERDIN; PROTEIN; SC5B 9 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CREATININE CLEARANCE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; URINARY EXCRETION;

BIOLOGICAL MARKERS; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MIDDLE AGED; PROGNOSIS; PROPERDIN; PROTEINURIA;

EID: 77950233806     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp630     Document Type: Article

References (37)

1. Abbate M, Zoja C, Corna D, et al. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9: 1213-1224
2. Burton C, Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996; 27: 765-775
3. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Int Med 2004; 43: 9-17
4. Remuzzi G, Bertani T. Pathophysiology of progressive nephropa-thies. N Engl J Med 1998; 339: 1448-1456
5. Sheerin NS, Sacks SH. Chronic interstitial damage in proteinuria-does complement mediate tubulointerstitial injury? Kidney Blood Press Res 1999; 22: 47-52
6. Matsuo S, Morita Y, Mizuno M, et al. Proteinuria and damage to tubular cells-is complement a culprit? Nephrol Dial Transplant 1998; 13: 2723-2726
7. Morita Y, Ikeguchi H, Nakamura J, et al. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 2000; 11: 700-707
8. Ogrodowski JL, Hebert LA, Sedmak D, et al. Measurement of Sc5B-9 in urine in patients with the nephrotic syndrome. Kidney Int 1991; 40: 1141-1147
9. Schulze M, Baker PJ, Ochi R, et al. Urinary excretion of complement C5B-9 in experimental membranous nephropathy. Kidney Int 1987; 31: 329
10. Bexborn F, Andersson PO, Chen H, et al. The tick-over theory revisited: Formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol 2008; 45: 2370-2379
11. Biancone L, David S, Dellapietra V, et al. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994; 45: 451-460
12. Camussi G, Stratta P, Mazzucco G, et al. In vivo localization of C-3 on the brush-border of proximal tubules of kidneys from nephrotic patients. Clin Nephrol 1985; 23: 134-141
13. Camussi G, Tetta C, Mazzucco G, et al. The brush border of proximal tubules of normal human kidney activates the alternative pathway of the complement system invitro. Ann N YAcad Sci 1983; 420: 321-324
14. Peake PW, Pussell BA, Mackinnon B, et al. The effect of pH and nu-cleophiles on complement activation by human proximal tubular epithelial cells. Nephrol Dial Transplant 2002; 17: 745-752
15. Harboe M, Mollnes TE. The alternative complement pathway revisited. J Cell Mol Med 2008; 12: 1074-1084
16. Xu W, Berger SP, Trouw LA, et al. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol 2008; 180: 7613-7621
17. Kemper C, Hourcade DE. Properdin: new roles in pattern recognition and target clearance. Mol Immunol 2008; 45: 4048-4056
18. Spitzer D, Mitchell LM, Atkinson JP, et al. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 2007; 179: 2600-2608
19. Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 2006; 281: 2128-2132
20. Gaarkeuken H, Siezenga MA, Zuidwijk K, et al. Complement activation by tubular cells is mediated by properdin binding. Am J Physiol-Ren Physiol 2008; 295: F1397-F1403
21. Bartels H, Bohmer M, Heierli C. Serum creatinine determination without protein precipitation. Clin Chim Act 1972; 37193
22. Gerbaut L. Immunoturbidimetry of albumin in serum, cerebrospinal fluid and urine with a unique calibration curve. Clin Chem 1987; 33: 1260-1261
23. Watanabe N, Kamei S, Ohkubo A, et al. Urinary protein as measured with a pyrogallol red molybdate complex manually and in a Hitachi-726 automated analyzer. Clin Chem 1986; 32: 1551-1554
24. Mollnes TE, Lea T, Froland SS, et al. Quantification of the terminal complement complex in human-plasma by an enzyme-linked immu-nosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197-202
25. Fijen CAP, VandenBogaard R, Daha MR, et al. Carrier detection by microsatellite haplotyping in 10 properdin type 1-deficient families. Eur J Clin Invest 1996; 26: 902-906
26. He C, Imai M, Song HB, et al. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol 2005; 174: 5750-5757
27. Morita Y, Nomura A, Yuzawa Y, et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1997; 8: 1363-1372
28. Nangaku M, Pippin J, Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental ne-phrotic syndrome. J Am Soc Nephrol 1999; 10: 2323-2331
29. Hori Y, Yamada K, Hanafusa N, et al. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int 1999; 56: 2096-2106
30. Nangaku M, Pippin J, Couser WG. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002; 13
31. Abe K, Li K, Sacks SH, et al. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 2004; 136: 60-66
32. Tang ZY, Lu B, Hatch E, et al. C3a mediates epithelial-to-mesenchy-mal transition in proteinuric nephropathy. J Am Soc Nephrol 2009; 20: 593-603
33. Lutz HU, Jelezarova E. Complement amplification revisited. Mol Immunol 2006; 43: 2-12
34. Wirthmueller U, Dewald B, Thelen M, et al. Properdin, a positive regulator of complement activation is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997; 158: 4444-4451
35. Schwaeble W, Huemer HP, Most J, et al. Expression of properdin in human monocytes. Eur J Biochem 1994; 219: 759-764
36. Ferenbach D, Kluth DC, Hughes J. Inflammatory cells in renal injury and repair. Semin Nephrol 2007; 27: 250-259
37. Smith CA, Pangburn MK, Vogel CW, et al. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J Biol Chem 1984; 259: 4582-4588